The scientist’s investigation covers issues in Immunology, Lupus erythematosus, Immune system, Autoimmunity and Autoimmune disease. Antibody, Tumor necrosis factor alpha, Naive B cell, Dendritic cell and Antigen are among the areas of Immunology where the researcher is concentrating her efforts. Her work deals with themes such as Interleukin, Cytokine, Pathogenesis, Arthritis and Rheumatoid arthritis, which intersect with Tumor necrosis factor alpha.
Her Lupus erythematosus research is multidisciplinary, incorporating elements of Gene expression profiling, Interferon, Gene, Interferon type I and Systemic lupus erythematosus. Her Gene expression profiling study integrates concerns from other disciplines, such as Defensin, Alpha interferon, Disease and Granulopoiesis. The Immune system study combines topics in areas such as Myeloid and Secretion.
Her primary areas of investigation include Immunology, Immune system, Antibody, Lupus erythematosus and Gene. Her Immunology research incorporates elements of Systemic lupus erythematosus and Disease. Virginia Pascual has researched Immune system in several fields, including Myeloid and Transcriptome.
Her study in Antibody is interdisciplinary in nature, drawing from both Molecular biology and Antigen. Her research integrates issues of Interferon type I, Autoimmune disease and B cell in her study of Lupus erythematosus. Her Autoimmunity research is multidisciplinary, incorporating perspectives in Tumor necrosis factor alpha and Receptor.
Virginia Pascual mainly focuses on Immunology, Immune system, Systemic lupus erythematosus, Transcriptome and Lupus erythematosus. Her studies in Immunology integrate themes in fields like Lupus nephritis and Disease. Her Immune system research includes themes of Epitope, Effector, CD11c and Vaccination.
Virginia Pascual interconnects Myeloid, Autoimmune disease, Autoimmunity and Pathogenesis in the investigation of issues within Systemic lupus erythematosus. Her biological study spans a wide range of topics, including Lymphocyte and Cancer immunotherapy. As a member of one scientific family, Virginia Pascual mostly works in the field of Lupus erythematosus, focusing on T cell and, on occasion, Virus, Virology, Triple-negative breast cancer and Immunotherapy.
Her primary areas of study are Immunology, Systemic lupus erythematosus, Lupus erythematosus, Lupus nephritis and Autoimmune disease. The concepts of her Immunology study are interwoven with issues in Transcriptome and Disease. Virginia Pascual combines subjects such as Gene expression profiling, Cancer immunotherapy, Lymphocyte, Vaccination and Tuberculosis with her study of Disease.
The study incorporates disciplines such as Cell, Molecular network and Bioinformatics in addition to Systemic lupus erythematosus. Her Immune system study incorporates themes from Prospective cohort study, Asymptomatic, Pathology, Virus and Polymerase chain reaction. Virginia Pascual has included themes like Inducible T-Cell Co-Stimulator Protein, Cellular differentiation, Pathogenesis, Myeloid and OX40 ligand in her Antigen presentation study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Lynda Bennett;A. Karolina Palucka;Edsel Arce;Edsel Arce;Victoria Cantrell;Victoria Cantrell.
Journal of Experimental Medicine (2003)
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Matthew P. R. Berry;Christine M. Graham;Finlay W. McNab;Zhaohui Xu.
Nature (2010)
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Patrick Blanco;A. Karolina Palucka;Michelle Gill;Michelle Gill;Virginia Pascual;Virginia Pascual.
Science (2001)
Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion
Rimpei Morita;Nathalie Schmitt;Salah Eddine Bentebibel;Rajaram Ranganathan.
Immunity (2011)
Plasmacytoid Dendritic Cells Induce Plasma Cell Differentiation through Type I Interferon and Interleukin 6
Gaetan Jego;A. Karolina Palucka;Jean Philippe Blanck;Cecile Chalouni.
Immunity (2003)
Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus
Gina S. Garcia-Romo;Simone Caielli;Barbara Vega;John Connolly.
Science Translational Medicine (2011)
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
Virginia Pascual;Virginia Pascual;Florence Allantaz;Edsel Arce;Marilynn Punaro;Marilynn Punaro.
Journal of Experimental Medicine (2005)
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
Jacques Banchereau;Virginia Pascual.
Immunity (2006)
Analysis of somatic mutation in five B cell subsets of human tonsil.
V. Pascual;Yong-Jun Liu;A. Magalski;O. De Bouteiller.
Journal of Experimental Medicine (1994)
Defective B cell tolerance checkpoints in systemic lupus erythematosus
Sergey Yurasov;Hedda Wardemann;Johanna Hammersen;Makoto Tsuiji.
Journal of Experimental Medicine (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Immunai
Sidra Medical and Research Center
Baylor University
Baylor University
The Ohio State University
The Ohio State University
The Francis Crick Institute
The Francis Crick Institute
The University of Texas Southwestern Medical Center
The University of Texas MD Anderson Cancer Center
KU Leuven
University of Porto
North Carolina State University
University of Tasmania
University of South Carolina
Martin Luther University Halle-Wittenberg
University of California, San Diego
Duke University
Universidade de São Paulo
Meiji Pharmaceutical University
Jawaharlal Nehru University
Tel Aviv University
McGill University
The University of Texas Southwestern Medical Center
MIT
Apache Corporation